mMEDICI
mMEDICI is a Tokyo-based, founder-led Japanese public-health knowledge platform founded in April 2024, offering online schools, webinars, career support, and real-world data consulting to healthcare professionals, institutions, and pharmaceutical companies in Japan.
- Company typePrivate
- Founded2024
- HeadquartersTokyo, Japan
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What mMEDICI does
mMEDICI Inc. (mMEDICI株式会社) is a Tokyo-based, privately held Japanese corporation founded in April 2024 by Naoki Hirose (PhD, MPH), a former epidemiologist at Eli Lilly Japan and Johnson & Johnson Innovative Medicine. The company operates a "public health knowledge platform" consisting of six branded sub-products: mJOHNSNOW and mJOHNSNOW Business (online schools and community platforms for public-health and life-science professionals), mERASMUS (a webinar service featuring Japan's leading instructors), mDAVINCI (career support for life-science professionals), mNIGHTINGALE (real-world data utilization support for pharmaceutical and healthcare clients), and mMEDICI Library/mPEDIA (a web media aggregation of public health content). The platform is mobile-first, allowing professionals to learn during spare time via smartphone.
The underlying technology is a portfolio of online learning, webinar delivery, and community/chat-consulting products rather than a single integrated software platform; no proprietary AI/ML stack, no disclosed APIs or SDKs, and no app distribution are evidenced. Distribution is primarily self-serve through the company's mobile/web properties for individual learners, complemented by direct sales for corporate training and RWD consulting engagements with pharmaceutical companies and healthcare institutions.
mMEDICI monetizes through four revenue streams: recurring online-school and community subscriptions, webinar fees (with select free flagship events such as the Japan RWD Summit), professional-services fees for career support, and professional-services fees for real-world data consulting. Pricing tiers and per-unit economics are not publicly disclosed. The go-to-market motion is community-led and event-driven, leveraging content marketing through mPEDIA and YouTube, large-scale webinars, and the CEO's personal social-media presence (26,000+ X followers). Customer segments span individual healthcare professionals (doctors, nurses, physical/occupational therapists, pharmacists), academic and research institutions, healthcare providers (hospitals, clinics), and domestic and global pharmaceutical companies operating in Japan.
mMEDICI firmographics
Firmographics- Name
- mMEDICI
- Legal name
- mMEDICI Inc. (mMEDICI株式会社)
- Website
- https://mmedici.co.jp
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- mMEDICI is a Tokyo-based, founder-led Japanese public-health knowledge platform founded in April 2024, offering online schools, webinars, career support, and real-world data consulting to healthcare professionals, institutions, and pharmaceutical companies in Japan.
- Ownership category
- akta.pro rank
mMEDICI industry classification
Industry- Product category
- Public Health Education and Training Services
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518), Research and Development in the Social Sciences and Humanities (541720)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)
- akta.pro secondary industries
- Health Promotion & Public Health Education (Community Workshops) (EDAAAFAG), Multilingual, Accessibility & Health Literacy Enablement (HLACAEAN), Health Literacy (Navigating Care, Medication, Preventive Info) (EDAAAAAF), Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm) (HLACAIAF)
Keywords
Where mMEDICI is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
mMEDICI business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Online School & Community Subscriptions: Subscription-based access to mJOHNSNOW online school and community platform, offering courses, expert chat consulting, and learning materials for public health professionals and beginners.
- Webinar Services: Revenue from hosting professional webinars and online training events featuring Japan's leading public health experts, with both free and paid webinar offerings.
- Career Support Services: Career consulting and support services for life sciences professionals, researchers, and healthcare workers seeking to advance their careers.
- Real-World Data Consulting: Consulting services for pharmaceutical companies and healthcare organizations on real-world data utilization, including research support, business strategy, recruitment, education, branding, marketing, and sales support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Online school and community membership plans |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
mMEDICI product offering
Product offeringCore offering
mMEDICI operates an integrated public health knowledge platform combining an online school and community (mJOHNSNOW), an enterprise business learning community (mJOHNSNOW Business), a webinar service (mERASMUS), career support for life sciences professionals (mDAVINCI), real-world data utilization consulting (mNIGHTINGALE), and a public health web media library (mMEDICI Library/mPEDIA). The platform delivers expert-reviewed public health education accessible via smartphone to individual learners and corporate clients, with major events such as the Japan RWD Summit attracting 400-646+ participants.
Product overview
mMEDICI operates as a unified 'public health knowledge platform' offering a portfolio of six integrated services: mJOHNSNOW (online school & community), mJOHNSNOW Business (business learning community), mERASMUS (webinars), mDAVINCI (career support), mNIGHTINGALE (RWD utilization services), and mMEDICI Library/mPEDIA (WEB media). The platform is designed for public health professionals seeking to learn during spare time via smartphone, with services spanning education, career development, research support, and knowledge dissemination.
Differentiator
Problem solved
Functional benefit
Brands
- mJOHNSNOW: パブリックヘルス オンラインスクール＆コミュニティ - スキマ時間にスマホで学べる日本最大級のパブリックヘルスオンラインスクール＆コミュニティ
- mJOHNSNOW Business
- mERASMUS
- mDAVINCI
- mNIGHTINGALE
- mMEDICI Library
Products and services
- mJOHNSNOW Japan's largest public health online school and community, offering expert-curated courses accessible via smartphone during spare time. Features expert-reviewed lectures and chat-based consulting for beginners to advanced practitioners, designed for healthcare professionals and life sciences learners.
- mJOHNSNOW Business Japan's first business learning community for public health professionals, founded by public health business operators. Offers practical business consulting and networking, accessible via smartphone, for life sciences professionals seeking to build business expertise.
- mERASMUS Webinar service featuring Japan's leading public health instructors, offering on-demand access to specialized expertise. Provides courses from beginner to advanced levels, curated by researchers for quality assurance. Includes flagship programs such as mERASMUS Research Connect and the Japan RWD Summit.
- mDAVINCI Career support service for life science professionals, led by medical researchers and healthcare workers with corporate experience. Offers high-resolution career consulting to help professionals maximize their expertise, with related webinars on public health business and side-business topics.
- mNIGHTINGALE Real-World Data (RWD) utilization support service led by epidemiology experts with experience at global pharmaceutical companies. Provides comprehensive consulting including research assistance, business strategy, recruitment, education, branding, marketing, and sales support for pharmaceutical and healthcare organizations.
- mMEDICI Library (mPEDIA) WEB media platform (mPEDIA) aggregating public health wisdom, covering research, careers, learning, and graduate school admissions topics. Curated by public health specialists as an 'akashic record' for public health professionals.
Quantifiable outcome
- 91-98% satisfaction rate for major webinar events
- +2 more outcomes
Companies that use mMEDICI
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
mMEDICI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
mMEDICI partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- NTTプレシジョンメディシン (NTT Precision Medicine)coreStrategic partnership for advancing precision medicine initiatives. mMEDICI has entered into a partnership agreement with NTT Precision Medicine to collaborate on public health education and real-world data utilization in the precision medicine space.
- PRiME-RcoreStrategic partnership for research and education collaboration. PRiME-R joins mMEDICI and NTT Precision Medicine in a three-way partnership agreement to advance public health research and education capabilities.
Scale indicators4 records
Recent moves5 records
Expansion highlights6 records
mMEDICI competitors and assessment
Company assessmentDirect peers
- Real World Data Co., Ltd. Japanese RWD analytics and consulting firm supporting pharma evidence generation and HEOR. Directly comparable to mMEDICI's mNIGHTINGALE service in providing RWD utilization support to pharmaceutical clients operating in Japan.
- MedPeer: Japanese online community and continuing education platform for physicians with peer discussion, clinical content, and pharma-sponsored learning. Comparable in business model (community + sponsored educational content) and in serving Japanese clinicians seeking professional development.
- JMDC (Japan Medical Data Center): Japan's leading real-world data and health claims analytics company serving pharma, academia, and government. Directly comparable on the mNIGHTINGALE RWD-consulting axis, providing data and analytics that mMEDICI helps its customers consume.
- CareNet: Operates one of Japan's largest online medical learning and clinical information platforms for physicians, nurses, and pharmacists. Directly comparable as a Japan-based e-learning + community destination serving the same healthcare-professional audience that mMEDICI targets with mJOHNSNOW.
Regional players
- INTAGE Healthcare: Japanese healthcare marketing research and RWD subsidiary of INTAGE Group serving pharma and consumer health clients. Comparable on the real-world data and healthcare insight axis that mMEDICI's mNIGHTINGALE service competes against for pharma training and RWD enablement budgets.
- Pharma Next / Pharmaceutical Training Providers (CME Japan): Japan-based provider of continuing medical education and pharmaceutical professional development programs. Comparable as a domestic CME/CE-style training alternative that competes for the same hospital and pharma training wallets as mJOHNSNOW Business and mERASMUS.
Emerging players
- Schoo: Japan-focused live online learning platform with a video course library and business subscription model. Comparable as a domestic live-classroom and subscription e-learning operator, although its current curriculum skews business/tech rather than public health.
Broad incumbents
- Udemy Business: Global marketplace and enterprise subscription e-learning platform with a large catalog of healthcare, statistics, and public-health courses. Comparable as a much larger online-course subscription alternative that healthcare professionals may use alongside or instead of mMEDICI.
- Coursera: Global online learning platform partnering with universities (Johns Hopkins, etc.) to deliver public health, epidemiology, and biostatistics specializations. Comparable as a global destination for the same online public-health upskilling that mJOHNSNOW targets, and the brand mJOHNSNOW explicitly references.
- M3 (m3.com): Operates Japan's largest physician-only platform m3.com spanning medical news, survey panels, career services, and pharma marketing. Comparable as a much larger incumbent offering overlapping professional education, career, and pharma-engagement services to Japanese clinicians.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
mMEDICI social profiles
Digital presencemMEDICI financial estimates
Financial estimateRevenue estimate
Valuation estimate
mMEDICI leadership team
Management profileNumber of profiles
Profiles6 records
mMEDICI funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
mMEDICI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about mMEDICI
What does mMEDICI do?
mMEDICI operates an integrated public health knowledge platform combining an online school and community (mJOHNSNOW), an enterprise business learning community (mJOHNSNOW Business), a webinar service (mERASMUS), career support for life sciences professionals (mDAVINCI), real-world data utilization consulting (mNIGHTINGALE), and a public health web media library (mMEDICI Library/mPEDIA). The platform delivers expert-reviewed public health education accessible via smartphone to individual learners and corporate clients, with major events such as the Japan RWD Summit attracting 400-646+ participants.
Is mMEDICI a public or private company?
mMEDICI is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was mMEDICI founded?
mMEDICI was founded in 2024. It employs 1 to 10 people.
Where is mMEDICI based?
mMEDICI is headquartered in Tokyo, Japan, in the Asia region.
How does mMEDICI make money?
Four revenue lines are on record. Online School & Community Subscriptions are the primary driver. The others are webinar Services, career Support Services and real-World Data Consulting.
Who are mMEDICI's main competitors?
Direct peers on record are Real World Data Co., Ltd., MedPeer, JMDC (Japan Medical Data Center) and CareNet. Regional players are INTAGE Healthcare and Pharma Next / Pharmaceutical Training Providers (CME Japan). Schoo is listed as an emerging player. Broad incumbents are Udemy Business, Coursera and M3 (m3.com).
Does mMEDICI have an API?
No public API is recorded for mMEDICI.
What industry is mMEDICI in?
mMEDICI's product category is Public Health Education and Training Services. Its primary akta.pro industry code is EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE), with a secondary code of EDAAAFAG, Health Promotion & Public Health Education (Community Workshops). Its NAICS code is 518 and its SIC code is 8090.